Review Articles

Gastric pain

Natalie Schellack, Gustav Schellack, Nicolene van der Sandt, Bongiwe Masuku
South African Family Practice | Vol 57, No 5 : September/October| a4324 | DOI: https://doi.org/10.4102/safp.v57i5.4324 | ©
Submitted: 15 July 2015 | Published: 01 September 2015

About the author(s)

Natalie Schellack, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa
Gustav Schellack, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa
Nicolene van der Sandt, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa
Bongiwe Masuku, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa

Full Text:

PDF (84KB)

Abstract

Gastric pain may be generalised, diffused, specific to the right or left upper quadrant (or both), and may be attributed to a range of possible causes. Types of gastric pain include dyspepsia and epigastric pain. The term “gastric pain” is not frequently encountered in the literature. Therefore, the main focus of this review is on epigastric pain and dyspepsia, both of which are frequently encountered in the clinical setting. For example, it is estimated that dyspepsia affects a quarter of the global population. Several drugs and drug classes are also linked to a range of mechanisms through which the drugs induce mucosal injury in the upper gastrointestinal tract. Therefore, this article provides an overview of the aetiology, classification, risk factors, diagnostic criteria and management strategies aimed at gastric pain, and its two more distinct gastrointestinal-related manifestations, namely epigastric pain and dyspepsia.

Keywords

gastric pain; epigastric pain; dyspepsia; peptic ulcer disease (PUD); GORD; proton-pump inhibitors

Metrics

Total abstract views: 1365
Total article views: 991


Crossref Citations

No related citations found.